Bridgewater-based Cordis Corp. was ordered to pay $19.5 million last week after a jury found the company willfully infringed on a heart stent patent owned by Massachusetts-based Boston Scientific Corp.
Boston Scientific filed suit in 2009, claiming Cordis’ 2.25-millimeter Cypher stent infringed on the patent for Boston Scientific’s Jang stent. Last week, a jury in the U.S. District Court in Delaware awarded Boston Scientific $18.5 million in lost profits and another $1 million in royalties.
“We are pleased to see the jury recognize the value of our intellectual property,” said Hank Kucheman, executive vice president at Boston Scientific. “This is an important outcome in protecting our market position in small-vessel, drug-eluding stents against infringing products.”
Cordis is a Johnson & Johnson company. The company did not respond to a request for comment.
– Jared Kaltwasser